TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 4.149 million compared to TWD 3.196 million a year ago. Operating loss was TWD 67.857 million compared to TWD 60.827 million a year ago. Net income was TWD 60.454 million compared to net loss of TWD 97.425 million a year ago. Basic earnings per share was TWD 0.08 compared to basic loss per share of TWD 0.14 a year ago. Diluted earnings per share was TWD 0.08 compared to TWD 0 a year ago. For the half year, sales was TWD 8.698 million compared to TWD 19.978 million a year ago. Operating loss was TWD 126.487 million compared to TWD 107.587 million a year ago. Net income was TWD 6.375 million compared to net loss of TWD 122.887 million a year ago. Basic earnings per share was TWD 0.01 compared to basic loss per share of TWD 0.17 a year ago. Diluted earnings per share was TWD 0.01 compared to TWD 0 a year ago.